Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer

Area of Science:

• Oncology
• Biochemistry
• Immunology

Background:

• Cancer cells exhibit increased glycolysis, producing L-lactate which fuels tumor growth and immune evasion.
• Lactate's role as a tumor biofuel presents a therapeutic target for cancer treatment.
• Current research focuses on developing inhibitors targeting the glycolysis pathway.

Purpose of the Study:

• To investigate the efficacy of synthetic D-lactate dimers as inhibitors of cancer cell proliferation and survival.
• To evaluate the in vivo effects of D-lactate dimers on tumor growth and the host immune response.

Main Methods:

• Utilized synthetic D-lactate dimers to treat melanoma and squamous cell carcinoma cell lines in vitro.
• Administered D-lactate dimers via intratumoral injection in immunodeficient mice with subcutaneous melanoma xenografts.
• Assessed tumor growth inhibition and analyzed the induced innate immune response.

Main Results:

• D-lactate dimers demonstrated inhibition of melanoma and squamous cell carcinoma cell proliferation and survival.
• Intratumoral injection of D-lactate dimers led to inhibition of subcutaneous melanoma xenograft growth.
• The treatment induced a detectable innate immune response within the tumor microenvironment.

Conclusions:

• Synthetic D-lactate dimers show potential as a therapeutic agent for skin cancer treatment.
• Further mechanistic studies are warranted to fully understand the anti-cancer effects of D-lactate dimers.
• The findings suggest a novel approach targeting cancer metabolism and immune modulation.